CA

Irving William Wainer

This inventor holds 1 USPTO granted patent. Top assignee: Darwin Discovery Limited. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Irving William Wainer. Retrieved from https://idiyas.com/inventor/irving-william-wainer-lzo40wm2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Irving William Wainer

Introduction

Irving William Wainer is a notable inventor based in California, recognized for his contributions to antitumor therapy. His innovative approach focuses on the use of enantiomers of ifosfamide, a cytotoxic drug, to enhance treatment efficacy while minimizing side effects.

Latest Patents

Wainer holds a patent for the "Use of the enantiomers of ifosfamide in antitumor therapy for reducing - (R)-Ifosfamide is administered as a cytotoxic drug, in order to minimize side effects. (S)-Ifosfamide may be administered subsequently." This patent reflects his commitment to improving cancer treatment methodologies.

Career Highlights

Irving Wainer is associated with Darwin Discovery Limited, where he applies his expertise in drug development. His work has significantly impacted the field of oncology, showcasing his dedication to advancing medical science.

Collaborations

Wainer has collaborated with talented individuals such as Julie Ducharme and Helen Frances Baker, contributing to a dynamic research environment that fosters innovation.

Conclusion

Irving William Wainer's work exemplifies the intersection of science and innovation in the fight against cancer. His contributions continue to influence the development of effective therapies, making a lasting impact in the medical community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…